Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Item No. 39128
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Citrullinated fibrinogen (β chain) (R44 + R47 + R60) (41-62)-biotin peptide is a biotinylated version of a tri-citrullinated form of the secreted matrix protein fibrinogen, which has been found as the citrullinated form in plasma circulating immune complexes of patients with rheumatoid arthritis.1 Fibrinogen is subject to citrullination by peptidyl arginine deiminase 2 (PAD2) and PAD4, which can occur in the synovial fluid from patients with rheumatoid arthritis.2,3 Cayman's Citrullinated Fibrinogen (β Chain) (R44 + R47 + R60) (41-62)-biotin Peptide is intended for the detection of autoantibodies against fibrinogen citrullinated at R44, R47, and R60.
WARNING This product is not for human or veterinary use.
1. Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis. Arthritis Res. Ther. 10(4), R94 (2008).
2. Citrullination of fibrinogen by peptidylarginine deiminase 2 impairs fibrin clot structure. Clin. Chim. Acta 501, 6-11 (2020).
3. Demonstration of extracellular peptidylarginine deiminase (PAD) activity in synovial fluid of patients with rheumatoid arthritis using a novel assay for citrullination of fibrinogen. Arthritis Res. Ther. 16(6), 498 (2014).